ABBV vs VRT · P/E 81, rev $61.16B vs P/E 80, rev $10.23B
AbbVie Inc (ABBV) versus Vertiv Holdings Co (VRT) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Vertiv Holdings Co (VRT) is a electrical equipment & parts company listed on NYSE.
Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 305.0% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported VRT revenue for 2025-12-31 was $10.23B. Net income was $1.33B. Revenue was up 27.7% from 2024-12-31 to 2025-12-31. VRT currently screens at market cap $121.99B and trailing P/E 79.8.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. VRT currently screens at market cap $121.99B and trailing P/E 79.8.
Not investment advice. Open the ABBV and VRT stock pages for the full models.
Not investment advice.